Form 8-K - Current report:
SEC Accession No. 0001178913-10-002631
Filing Date
2010-10-12
Accepted
2010-10-12 16:21:45
Documents
4
Period of Report
2010-10-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zk1008881.htm 8-K 28098
2 EXHIBIT 4.1 exhibit_4-1.htm EX-4.1 87746
3 EXHIBIT 10.1 exhibit_10-1.htm EX-10.1 49318
4 EXHIBIT 10.2 exhibit_10-2.htm EX-10.2 48101
  Complete submission text file 0001178913-10-002631.txt   215102
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905 972-4-850-1080
PLURISTEM THERAPEUTICS INC (Filer) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-31392 | Film No.: 101119452
SIC: 2836 Biological Products, (No Diagnostic Substances)